
GHRP-25 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
GHRP-2, explained simply
A synthetic peptide studied for its ability to stimulate growth hormone release.
Research area
Growth hormone axis and endocrine responses
How it works
Binds the ghrelin-related growth hormone secretagogue receptor and can elicit a pulsatile pituitary response.
Why it matters
It illustrates the difference between a secretagogue, which stimulates endogenous release, and administering growth hormone directly.
What has been observed
Studies describe hormonal responses in adults and children with growth deficiency; they do not establish general body-composition benefits.
Effects and points to consider
Endocrine responses vary by population and context. These studies do not define the long-term effects of practices shown in the profiles.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 5 mg GHRP-2 |
|---|---|
| Final volume | 3 mL |
| Concentration | 1.67 mg/mL |
| One U-100 unit | 16.67 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units (0.06 mL) |
| Weeks 3–4 | 150 mcg | 9 units (0.09 mL) |
| Weeks 5–8 | 200 mcg | 12 units (0.12 mL) |
| Weeks 9–12 | 200 mcg | 12 units (0.12 mL) |
| Weeks 13–16 | 200 mcg | 12 units (0.12 mL) |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.